Genetic Testing and Cancer
Luxor Scientific is CLIA-certified and CAP accredited laboratory that surpasses the standards of diagnostic testing. Specialists are available to discuss individual needs and customizable panels.
Luxor Scientific is CLIA-certified and CAP accredited laboratory that surpasses the standards of diagnostic testing. Specialists are available to discuss individual needs and customizable panels.
Cancer Carrier Screening
Sample Type: Blood, Buccal swab
Turnaround time: 2-3 weeks
Specific genetic variants are associated with an increased risk of developing certain cancers. Testing for genetic variants provides information to determine the most effective and efficient treatment plans. Contact the laboratory for most up to date listing of available cancer screening targets.
Alzheimer’s Disease
Sample Type: Blood, Buccal swab
Turnaround time: 2-3 weeks
The Alzheimer’s panel examines multiple genes known to be associated with an increased risk of Alzheimer’s disease and genetic disorders that cause dementia. Both early and late onset Alzheimer’s have a genetic component. Genetic testing can provide results to best determine treatment, psychosocial counseling and support programs.
Inherited Cardiomyopathy
Sample Type: Blood, Buccal swab
Turnaround time: 2-3 weeks
The cardiomyopathy panel examines an extensive list of genes associated with hereditary cardiomyopathies. This test can benefit patients with personal or family history that is suggestive of hereditary cardiomyopathy and patients with symptoms of cardiomyopathy. Results of this testing can help guide treatment plans.
Pharmacogenetics
Sample Type: Blood, Buccal swab
Turnaround time: 1-2 weeks
Our PGX testing helps reduce trial and error in the medication-assisted treatment of a wide variety of conditions. Altered metabolic activity of one or more major CYP enzymatic pathways is highly prevalent and contributes to variable patient medication responses. Improve the efficacy of patient treatment plans using Luxor’s Pharmacogenetic testing results and reduce risks and costs associated with ineffective and/or potentially harmful medications.
Luxor’s PGX Testing can be ordered by medical specialty, by medication class, and by individual gene-drug pairs.